The Immune System
Under Control
Our Company
AbolerIS Pharma is a Belgian biopharmaceutical company developing a novel approach to the treatment of chronic autoimmune and inflammatory diseases.
Lead Program
AbolerIS Pharma is developing a first-in-class monoclonal antibody based on a novel scientific approach to restore the balance in the immune system.
Our novel and unique therapeutic approaches induce immune tolerance and preserve useful immune responses in inflammatory, autoimmune, and degenerative diseases.
Latest updates
Nantes, France, November 22, 2022 – AbolerIS Pharma is a pre-clinical stage biotech company specialized in the development of innovative immunomodulators for the treatment of transplant rejection, graft-versus-host-disease and auto-immune…
21 & 22 November, 2023Antwerp, BelgiumThis two day event comprises presentations from several (international) key-note speakers, invited speakers and selected abstract presentations in plenary sessions as well as in break…
13 November, 2023London, UKThe annual, European Lifestars Awards (ELAs) bring together hundreds of European life science leaders, investors, partners and deal makers. It is a celebration of the success stories,…